References in periodicals archive ?
Zengen's novel molecules were developed from more than 25 years of original research in the US, Europe and Asia on peptide molecules derived from alpha-Melanocyte-Stimulating Hormone (alpha-MSH).
announced today that its researchers have discovered that supplementation with alpha-Melanocyte-Stimulating Hormone (alpha-MSH), a naturally occurring molecule that modulates inflammatory and immune responses, may be beneficial in patients with brain injury.
Zengen's proprietary molecules were developed from more than 25 years of original research in the US, Europe and Asia on peptide molecules derived from alpha-Melanocyte-Stimulating Hormone (alpha-MSH).